"

Chapter 9 Selected Diseases and Disorders of the Endocrine System

9p9 Type I Diabetes Mellitus

Zoë Soon

Overview

  • Also called insulin-dependent diabetes mellitus (IDDM).
  • Formerly known as juvenile diabetes due to early onset, typically during childhood.
  • Less common than Type II, accounting for about 10% of diabetes cases.
  • Usually more severe because of acute complications if blood glucose is not well-controlled.
  • Body weight: Usually thin due to increased catabolism caused by lack of insulin.

Causes

  • Autoimmune destruction of pancreatic beta cells in the islets of Langerhans.
  • Leads to little or no insulin production.
  • Thought to be triggered by several possible factors:
    • Viral exposures: Epstein-Barr virus, cytomegalovirus, mumps.
    • Genetics: Runs in families (family history)
    • Geographic factors: Higher prevalence away from the equator, e.g., Finland.
    • Not linked to obesity (unlike Type II).

Typical Onset:

  • Rapid development in children.
  • Can occur in adults as a latent autoimmune diabetes variant.

Pathophysiology:

  • Lack of insulin prevents glucose entry into cells,
    • as cell’s require insulin to insert GLUT4 glucose transporters into their cell membranes.
    • leading to high blood glucose levels (hyperglycemia).
  • Cells become starved for glucose, impairing ATP production.
  • Excess glucose diffuses into urine, drawing water and causing polyuria, causing
  • Dehydration triggers thirst (polydipsia).
  • The body responds by breaking down proteins and fats for energy:
    • Gluconeogenesis: Produces glucose from proteins and fats.
    • Lipolysis: Leads to high lipid levels (lipidemia).

Effects on the Body

  • Muscle wasting due to protein breakdown.
  • High blood lipids increase risk of atherosclerosis.
  • Ketone production causes ketosis and potentially ketoacidosis:
    • Blood becomes acidic.
    • Ketones and glucose are excreted in urine (ketonuria and glucosuria).

Signs and Symptoms:

  • Polydipsia:  Increased thirst (due to dehydration)
  • Polyphagia:  Increased hunger
  • Polyuria:  Increased urine volume (due to glucosuria and osmotic diuresis)
  • Fatigue (due to cell’s reduced ability to uptake glucose)
  • Blurred vision (due to retinopathies and diabetic cataracts)
  • Slowed healing of wounds (due to cell’s reduced ability to uptake glucose)

Diagnostic Blood Tests:

  1. Glycated hemoglobin (A1c) test
    • Measures the percentage of hemoglobin with blood sugar attached.
    • Reflects blood glucose control over 2-3 months.
    • Levels above 6.5% suggest diabetes.
  2. Random blood sugar test
    • Blood sample taken randomly, regardless of fasting.
    • Blood glucose above 110 mg/dL indicates abnormality.
  3. Fasting blood sugar test
    • Fasting for 12 hours before testing.
    • Normal: <100 mg/dL.
    • Diabetic: >125 mg/dL.

Treatments:

  • Insulin injections are essential.
  • No known preventive cause or cure; management focuses on blood sugar control.
    • Note:  Pancreatic transplants are challenging, and are not curative as the underlying cause of autoimmune destruction of the pancreatic beta cells by auto-antibodies and WBCs still exists.

Complications of Uncontrolled Diabetes and Risk of Long-Term Damage:

  • Blood vessel damage leads to:
    • Atheromas formation.
    • Vascular damage affecting organs. and putting person at risk for:
      • Cardiovascular disease: Stroke, heart attack, peripheral vascular disease.
      • Kidney failure (due to nephropathy).
      • Nerve damage: Neuropathy
      • Pregnancy complications: Stillbirths and miscarriages.
      • Increased risk of amputations due to ischemia and gangrene.
      • Eye damage: Leading to blindness (diabetic retinopathy).

 

  • Blurred Vision or Vision Loss: 
    • also due to development of diabetic (sugar) cataracts

Summary

  • In Type Iautoimmune destruction results in insulin deficiency.
  • Autoimmune origin causes destruction of beta cells in pancreatic islets of Langerhans.
  • Blood glucose regulation is severely impaired.
  • Rapid onset in children, generally non-obese.
  • Requires lifelong insulin therapy.
  • Precursors and triggers are still under study.
  • The condition leads to vascular damage affecting multiple organs and systems, emphasizing the importance of tight blood glucose control.

License

Icon for the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License

9p9 Type I Diabetes Mellitus Copyright © by Zoë Soon is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License, except where otherwise noted.

Share This Book